- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02380638
Effects of Whole-body Vibration Training on Body Composition in Adolescents With and Without Down Syndrome
February 27, 2015 updated by: José A. Casajús, Universidad de Zaragoza
Effects of Whole-body Vibration Training on Bone Mass and Bone Metabolism in Adolescents With Down Syndrome / Efectos Del Entrenamiento Vibratorio en la Masa ósea y el Metabolismo óseo de Adolescentes Con síndrome de Down
The main aims of the present project include 1) to study the longitudinal effects of whole-body vibratory exercise on bone metabolism in adolescents with and without DS and 2) to evaluate whether a low frequency vibratory training program consisting of 3 sessions per week for 9 months (each vibratory session last approximately 10 minutes and includes 5-6 bouts of 1 min with 1 min rest between bouts) can improve bone development in these populations.
Finally, and additional aim of the project is 3) to determine how long these effects may last after the end of the intervention.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zaragoza, Spain, 50009
- GENUD Research group
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 19 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Both groups: Ages 10 - 19.
- Both groups: Parental/guardian permission (informed consent) and if appropriate, child verbal assent.
- Down syndrome group only: Diagnosis of Down syndrome.
Exclusion Criteria:
- Taking medication affecting bone.
- Non-caucasian.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DS-WBV
Exercise with Whole-body vibration (WBV) platform (Power Plate®).
The participants will perform squat on a vibratory platform (3 times per week; 10 repetitions 30 to 60 seconds; Frequency: 25-30 Hz; Amplitude: 2 mm).
|
|
|
No Intervention: DS-NONWBV
This group will continue with their day-to-day lifestyle during the course of the project.
|
|
|
Experimental: NONDS-WBV
Exercise with Whole-body vibration (WBV) platform (Power Plate®).
The participants will perform squat on a vibratory platform (3 times per week; 10 repetitions 30 to 60 seconds; Frequency: 25-30 Hz; Amplitude: 2 mm).
|
|
|
No Intervention: NONDS-NONWBV
This group will continue with their day-to-day lifestyle during the course of the project.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes from baseline in body composition assessed with dual energy X-ray at different time points, 6 months and 15 months.
Time Frame: Changes from baseline in body composition at 6 months and changes from baseline in body composition at 15 months
|
Changes from baseline in body composition at 6 months and changes from baseline in body composition at 15 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes from baseline in bone structure evaluated with peripheral quantitative computed tomography at different time points, 6 months and 15 months.
Time Frame: Changes from baseline in bone structure at 6 months and changes from baseline in bone structure at 15 months
|
Changes from baseline in bone structure at 6 months and changes from baseline in bone structure at 15 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: José A. Casajús, MD, PhD, GENUD Research group
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
February 20, 2015
First Submitted That Met QC Criteria
February 27, 2015
First Posted (Estimate)
March 5, 2015
Study Record Updates
Last Update Posted (Estimate)
March 5, 2015
Last Update Submitted That Met QC Criteria
February 27, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DEP2009-09183
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.